中医药治疗蛛网膜下腔出血研究进展
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R277.7

基金项目:

广东省自筹经费类科技计划项目(2017ZC0189)


Research Progress of Chinese Medicine in Treating Subarachnoid Hemorrhage
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    蛛网膜下腔出血是一种高致残率、高死亡率的急危重症。从中医药对蛛网膜下腔出血病因病机、辨证分型、方药论治认识以及基础研究进展等方面进行综述,中医药治疗蛛网膜下腔出血有多层次、多系统、多靶点等特点,体现出一定的治疗优势。但是在统一辨证分型与疗效判断标准,实施大样本的循证医学研究等方面仍需进一步探索,以期更好的指导中医药理论与临床研究。

    Abstract:

    Abstract:Subarachnoid hemorrhage is an acute and severe disease with a high disability rate and a mortality rate. The etiology, pathogenesis, syndrome differentiation, prescriptions, and the basic research progress of subarachnoid hemorrhage from the perspective of Chinese medicine were summarized. The treatment of subarachnoid hemorrhage with Chinese medicine has the characteristics of multi-level,multi-system,and multi-target,which reflects certain treatment advantages. However, there should be a further exploration of unifying criteria for syndrome differentiation and judging curative effect,implementing evidence-based medicine research based on a larger sample,etc,so as to better guide the theory and clinical research of Chinese medicine.

    参考文献
    相似文献
    引证文献
引用本文

胡明哲,陈香岩,陈发军.中医药治疗蛛网膜下腔出血研究进展[J].新中医,2020,52(20):18-20

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-10-19
  • 出版日期:
文章二维码